BAD and neoplasm: This particular feature of BAD-LAMP seems to be exploited in tumour infiltrating pDCs, since higher expression of BAD-LAMP in pDCs exposed to tumour microenvironments contribute to their functional impairment and incapacity to produce type-I IFN, both associated with poor prognosis.